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837-I Influence of Etiology on the Survival Advantage of 
Women With Advanced Heart Failure 
J&l K. Ghali Heidi J. Krause-Steinrauf, Kirkwood F. Adams, Jr., Steven S. Khan, Yves -9 
D. Rosenberg, Clyde W. Yancy. James ??. Young, Steven Goldman, Mary A. Peberdy, 
JoAnn Lindenfeld, Cardiac Centers of Louisiana, Shreveport, LA 
Background: The survival advantage for women with heart failure (HF) and impaired left 
ventricular ejection fraction (LVEF) has been reported in some but not all studies to be 
confined to patients with non-ischemic etiology. Methods: The impact of etiology on sur- 
vival by gender was assessed in the Beta-Blocker Evaluation of Survival Trial (BEST) 
which randomized 2708 HF patients with NYHA class Ill/IV and LVEF < 0.35 to bucin- 
dolol vs placebo. All women (n = 593) were compared to non-Veteran’s Administration 
Hospital men (n = 1218). Mean duration of follow-up was 2.0 years. Results: A multivari- 
ate model comparing survival of females to males and adjusting for variables affecting 
prognosis including age. systolic blood pressure, LVEF, diabetes, creatinine, NYHA 
class, ethnicity, gender and etiology indicates that gender is a significant predictor of out- 
come (p = 0.0039). There was a significant coronary artery disease (CAD) by gender 
interaction (p = 0.0054). The effect of gender on survival wee modified by etiology 
(ischemic vs non-ischemic). In the ischemic group there was a trend for a better survival 
in men (p = 0.0813). However, in the non-ischemic group women had a better survival 
than men (p = 0.0083). Conclusion: The suwival advantage of women in BEST was 
confined to patients with non-ischemic etiology. Designing future euwival HF trials should 
include stratification by gender and etiology 
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837-2 The Association of the Heart Failure Score With 
Mortality and Hospitalizations in Pacemaker Patients 
Eldrin F. Lewis, Marc A. Pfeffer, Anne S. Hellkamp, Arnold J. Greenspon, Christian 
Machado, Steven Singh, John H. McAnulty, Eleanor Schron, Kerry L. Lee, Gewasio A. 
Lamas, Brigham 8 Women’s Hospital, Boston, MA, Mount Sinai Medical Center, Miami, 
FL 
Background: Patients (pt) with decompensated heart failure (HF) are increasingly bemg 
managed es outpatients. Therefore, hospitalization for HF may not be a sensitive 
aseesement of pt limitations due to HF. The objective of this study was to validate the 
Hearl Failure Score (HFS) as an outpatient HF tool. 
Methods: Pte enrolled in the Mode Selection Trtal (MOST) in Sinus Node Dysfunction 
were assessed at 1, 3, 6, and 12 months post-pacer implantation using the HFS. HFS 
has 4 ordinal subxales assessing: HF symptoms, physical signs of left and right HF, and 
therapy changes for HF. HFS was summed at each visit (ranging from 0 to 14) with lower 
scoree representing less HF. Pts who suwived AND were not hospitaltzed for HF the 1st 
year (n=1184) were evaluated (3 year mean follow-up). 
Results: Pts [median age 74 (68. 79), 53% male, 61% hypertension, 19% diabetes, 21% 
prior myocardial infarctcon] had a median HFS of 4 (25”, 75’” 1.8) at 1 year. Pts with a 
HFS 2 4 were more likely to die compared to pts with HFS of 0 (15.0% versus 4.7%, 
p=O.OOOl). Each l-point increase in HFS was associated with a subsequent increased 
risk of death (Hazard Ratio 1 .lO, 95% Cl 1.07-l .12. p=O.OOOl) and an 11% higher risk of 
future HF hospitalization (p=O.OOOl). The relationship between HFS and outcomes was 
similar regardless of pacing mode. 
Conclusion: Increasing HFS i$ associated with an increased risk of mortality and future 
hospitalization for HF in pts that survive one year after receiving pacemakers. HFS may 
be a useful HF endpoint for clinical trials. 
Cumulative Heart Failure Numb Perce Mortality Heart Failure 
score sr nt Rate Hospitalization 
0 233 20% 11 (5%) 7 (3%) 
1-3 323 27% 25 (6%) 13 (4%) 
4-8 393 33% 50 (13%) 26 (7%) 
,9 235 20% 44 (19%) 24 (10%) 
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837-3 Physician Specialty and Survival Following 
Hospitalization for Heart Failure 
JoAnne M. Foody, Saif S. Rathore, Yongfei Wang, Jeph Herrin, Frederick A. Masoudi, 
Edward P. Havranek, Martha J. Radford. Diana L. Ordin. Harlan M. Krumholz, for The 
Center for Medicare & Medicaid Services National Heart Care Project, Yale University 
School of Medicine, New Haven, CT, Colorado Foundation for Medical Care, Denver, CO 
Background: Specialty care may improve outcomes across a range of cerdiovabcular 
conditions including myocardial infarction, and unstable angina. Whether cardiologist, 
internist or family/general practitioner care is associated with improved survival in heart 
failure remains to be determined. 
Methods: We sought to determIne whether physician specialty is associated with 30-day 
or l-year mortality in a nationwide sample of 25,869 Medicare beneficiaries aged 65 
years or older hospitalized with a primaly discharge diagnosis of heart failure between 
April 1998 and March 1999. Weighted hierarchical logistic regression model was 
employed to evaluate the independent effect of physician specialty on 30-day moltality 
and 1 -year mortality. 
Results: Significant differences in patient characteristics and quality of care existed 
among patients cared by different physician specialty. Pabents treated by cardiologists 
had lower crude 30-day (cardiologists: 8.8%, internists: 9.0%, family/general practitio- 
ners: 11.9%; PcO.001) and 1 -year mortality rates (cardiologlets: 34.8%. internists: 40.1%, 
and family/general practitioners: 39.8%; P <O.OOl). Although patients treated by inter- 
nists had similar adjusted mortality risks as patients treated by cardiologists at 30-days 
(OR 0.93 (95 percent confidence interval, 0.81 to 1.06)), adjusted survival rates were 
woree at 1 year (OR 1.22, 95 percent confidence interval, 1.14 to 1.32). Patients cared 
for by general/family practitioners were at higher risk of mortality than patients cared for 
by cardiologists at 30 days (OR 1.31, 95 percent confidence interval, 1.14 to 1.52) and 
one-year 1.30 (95 percent confidence interval, 1.19 to 1.42). 
Conclusions: Heart failure patients cared for by cardiologists had improved long-term 
mortality compared with those cared for by internists, family practitioner$, or general 
practitioners. Differences in patient characteristkx or quality indicators do not account for 
these differences in mortality. Further studies are required to identify unique aspects of 
specialty care that lead to improved long-term clinical outcomes in older patients with 
heart failure. 
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837-4 Racial Differences in Mortality Among Elderly Patients 
Hospitalized With Heart Failure 
Saif S. Rathore, JoAnne M. Foody, Yongfei Wang, Grace L. Smith, Jeph Hernn, 
Frederick A. Masoudi, Diana L. Ordin, Edward L. Havranek. Harlan M. Krumholz, Yale 
University School of Medicine, New Haven, CT, Colorado Foundation for Medical Care, 
Aurora, CO 
Background: Previous studies have reported conflicting findings concerning the associ- 
ation of race and outcomes after hospitalization for heart failure (HF). We sought to 
determine whether raaal differences in survival exlet in a contemporary national cohort of 
community-based, insured, elderly patients hospitalized for HF and if racial differences 
were independent of patient, physician, and hospital factors. 
Methods: We evaluated racial differences in mortality after HF hospitalization using 
patients drawn from the National Head Failure Project, a Centers for Medicare 8 Medic- 
aid Services study of Medicare beneficiaries hospitalized with a primaly discharge diag- 
nosis of HF between 4/1998 and 311999. Black and white patients age X5 years who 
presented with HF by means of direct admission (n=29,732), were evaluated for moltality 
within 30 days and one year after admission. Multivariable hierarchical logistic regression 
was conducted to aesess the independent association of race with mortality adjusting for 
patient sex. age, medical history, left ventricular ejection fraction, admission characteris- 
tics, attending physician, and hospital characteristics. 
Results: Black patients had lower crude 30-day (6.3% vs. 10.7% white, P<O.OOl) and 
one-year mortality rates (31.5% vs. 40.1% white, P<O.OOl) than white patients. After mul- 
tivariable adjustment, black patients had lower mortality risks than white patients 30 days 
after admission (black/white risk ratio [RR] 0.82, 95% confidence intewal [Cl] 0.71 to 
0.94). Black patients had a lower mortality risk one year after admission (black/white RR 
0.88, 95% Cl 0.62 to 0.94). although the effect of race varied by hospital (PcO.001 for 
‘random’ race effect). 
Conclusion: Contrary to prior reports. black Medicare patients had lower crude mortality 
rates up to one year after hospitalization for HF than white patients. Patient race was not 
associated with mortakty after multivariable adjustment for patient, physician, and hospi- 
tal characteristics in a national cohort of elderly Medicare patients, although the effect of 
race varied by hospital. 
